World Health Assembly: Pandemic Flu Framework Clears Committee 27/05/2013 by William New, Intellectual Property Watch 1 Comment Member states gathered at the annual World Health Assembly took note of a report on its pandemic influenza preparedness (PIP) framework amid encouragement by developed countries that standard agreements for transferring materials be completed, and reminders from some developing countries of the need for fair access and benefit-sharing of the resulting treatments.
Focus On Quality For Patients Saves Billions Of Dollars 27/05/2013 by Intellectual Property Watch Leave a Comment Daniela Bagozzi writes: Ten years of efforts in treatment for priority diseases has yielded impressive results both in terms of lives and dollars saved. To maintain progress in a volatile and financially tight environment countries and the international community will need to increase pressure on quality and healthy generic competition.
World Health Assembly: Committee Breaks Deadlock On Poor Quality Meds Mechanism 26/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 3 Comments Breaking six months of deadlock, WHA members reached a compromise in committee on the issue of which country should preside over the global mechanism on poor quality medicines by supporting Brazil’s proposal to rotate the steering committee chairmanship. The Assembly will likely approve the decision.
World Health Assembly: Drafting Group Agrees On Health R&D Meeting Proposal 25/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 1 Comment An informal drafting group finalised a text today, proposing to convene a technical meeting to help identify new health research and development projects for diseases that primarily affect poor communities.
WIPO Members Debate Reduction Of PCT Fees; Send Back PPH Proposal 25/05/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment Members of the World Intellectual Property Organization Patent Cooperation Treaty (PCT) met this week to discuss possible amendments to the regulations under the treaty. Among issues discussed were possible fee reductions, the proposed formal integration of the Patent Prosecution Highway into the treaty, and the coordination of technical assistance under the treaty.
World Health Assembly: Members Debate US Proposed Advisory Meeting On Health R&D 24/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 1 Comment Taking the World Health Assembly by surprise, the US delegation today made a proposal to advance progress on the monitoring, coordination, and financing of health R&D in committee discussions today. Their suggestion to convene an advisory meeting is being discussed in an informal drafting group in a side room. The committee has adjourned until Monday, but the drafting group will continue over the weekend.
At WTO, LDC Fight For Extension Of TRIPS Transition Continues 24/05/2013 by William New, Intellectual Property Watch 3 Comments Over the past week or so, least-developed country (LDC) members of the World Trade Organization have held their own in a closed room with the world’s biggest economies as they worked out details of a request by the LDCs to extend the deadline by which they must enforce WTO intellectual property rules.
GI Proponents Assess Progress, Challenges; French Minister Blasts Large-Scale Agriculture 24/05/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment Bordeaux, France – In a stronghold of French gastronomy and famous regional products an industry organisation lobbying for the protection of geographical indications chose this week to convene its general assembly and set the goals for future actions.
WHO Should Have The Evidence? Ben Goldacre Refutes WHO Director’s Claim 24/05/2013 by Intellectual Property Watch 2 Comments “Bad Science” adversary and journalist, Dr Ben Goldacre, this week challenged WHO Director of Ethics and Social Determinants of Health, Dr Rüdiger Krech, on his understanding of published evidence.
World Health Assembly: Groups Seek To Return Focus To ‘Broken’ Medical R&D System 24/05/2013 by Brittany Ngo for Intellectual Property Watch and William New Leave a Comment The issue of access to medicines is on the agenda at this week’s World Health Assembly (WHA) and public health advocates are seeking greater clarity and detail about the latest member state effort to address failings in the global system of research and development for medical products.